Bank of America’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-36
| Closed | -$106 | – | 5944 |
|
|
2025
Q4 | $106 | Buy |
36
+9
| +33% | +$33 | ﹤0.01% | 6809 |
|
|
2025
Q3 | $152 | Buy |
27
+25
| +1,250% | +$124 | ﹤0.01% | 7775 |
|
|
2025
Q2 | $14 | Sell |
2
-10
| -83% | -$87 | ﹤0.01% | 8274 |
|
|
2025
Q1 | $109 | Sell |
12
-6,881
| -100% | -$62.3K | ﹤0.01% | 7812 |
|
|
2024
Q4 | $61.8K | Buy |
6,893
+1,390
| +25% | +$64.3K | ﹤0.01% | 6567 |
|
|
2024
Q3 | $353K | Buy |
5,503
+3,401
| +162% | +$224K | ﹤0.01% | 5704 |
|
|
2024
Q2 | $158K | Buy |
2,102
+1,456
| +225% | +$140K | ﹤0.01% | 6016 |
|
|
2024
Q1 | $77.2K | Buy |
646
+645
| +64,500% | +$69.9K | ﹤0.01% | 6369 |
|
|
2023
Q4 | $44 | Buy |
+1
| New | +$74 | ﹤0.01% | 7514 |
|
|
2023
Q1 | – | Sell |
-1
| Closed | -$34 | – | 7852 |
|
|
2022
Q4 | $34 | Buy |
+1
| New | +$60 | ﹤0.01% | 7869 |
|
|
2022
Q3 | – | Sell |
-5
| Closed | -$1K | – | 7872 |
|
|
2022
Q2 | $1K | Buy |
+5
| New | +$714 | ﹤0.01% | 7850 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8302 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8255 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8131 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7781 |
|
|
2020
Q2 | – | Sell |
-5
| Closed | -$2K | – | 6849 |
|
|
2020
Q1 | $2K | Buy |
+5
| New | +$3.35K | ﹤0.01% | 6623 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7110 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7273 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7201 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7136 |
|
|
2018
Q4 | – | Sell |
-1
| Closed | -$712 | – | 7134 |
|
|
2018
Q3 | $1K | Buy |
+1
| New | +$1.18K | ﹤0.01% | 7110 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 7065 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 7126 |
|
|
2016
Q1 | – | Hold |
0
| – | -$1K | – | 7034 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 7181 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6956 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 6954 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6621 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 7392 |
|
Other funds holding CLRB
BL
VCM
RCA
SFA
VFT
WAM
TRCT
Bank of America's CLRB Position: Q1 2026 in Review
Bank of America sold out of Cellectar Biosciences (CLRB) in Q1 2026, closing a stake of 36 shares — an estimated $106 sold.
Bank of America first reported a position in CLRB in Q3 2018 and held it in 13 quarters. The position peaked at $353K in Q3 2024. 19 funds tracked by Wall St. Rank hold CLRB as of Q1 2026.
- Bank of America reported no remaining Cellectar Biosciences position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 36 Cellectar Biosciences shares in Q1 2026, an estimated $106.
- Bank of America first reported a position in Cellectar Biosciences in Q3 2018 and held it in 13 quarters.
- Bank of America's Cellectar Biosciences position peaked at $353K in Q3 2024.
- 19 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.